<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SLDB
Solid Biosciences
$
()


  • Solid Biosciences just upgraded at JPMorgan, here's why

    7/15/2024 - 05:03am
  • Solid Biosciences joins Russell 3000 Index

    7/1/2024 - 08:24am
  • Planet Fitness upgraded, Comcast downgraded: Wall Street's top analyst calls

    6/24/2024 - 09:30am
  • Leerink upgrades Solid Biosciences with 'value-creating catalysts' in sight

    6/24/2024 - 06:17am
  • Leerink gets more bullish on Solid Biosciences, upgrades shares

    6/24/2024 - 06:12am
  • FDA's Sarepta decision 'positive' for gene therapy, STATNews reports

    6/21/2024 - 10:28am
  • Piper sees opportunity for Solid Biosciences after broad Elevidys approval

    6/21/2024 - 06:49am
  • Pfizer DMD gene therapy miss paves way for Sarepta, Solid Biosciences, says Citi

    6/13/2024 - 13:18pm
  • Solid Biosciences transferred with Overweight rating at Piper Sandler

    5/31/2024 - 05:07am
  • Solid Biosciences price target lowered by $2 at JPMorgan, here's why

    5/31/2024 - 04:35am
  • Solid Biosciences price target lowered by $3 at Barclays, here's why

    5/16/2024 - 05:10am
  • Solid Biosciences expects cash to fund strategic priorities into 2026

    5/15/2024 - 08:01am
  • Solid Biosciences to initiate dosing in Phase 1/2 trial of SGT-003 in Q2

    5/15/2024 - 08:01am
  • Solid Biosciences reports Q1 EPS (64c), consensus (64c)

    5/15/2024 - 07:59am
  • Solid Biosciences receives Rae Pediatric Disease designation for SGT-003

    4/1/2024 - 07:47am
dynamic_feed Breaking News